BALAXI PHARMACEUTICALS LIMITED (NSE:BALAXI) — Stock Price
BALAXI PHARMACEUTICALS LIMITED (NSE:BALAXI) is currently trading at Rs24.20 INR, down 0.49% today. Over the past 52 weeks, shares have ranged between Rs15.67 and Rs48.75. This page tracks BALAXI PHARMACEUTICALS LIMITED's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of BALAXI PHARMACEUTICALS LIMITED.
BALAXI PHARMACEUTICALS LIMITED (BALAXI) Stock Price Chart — Daily History & Trading Volume
The chart below tracks BALAXI PHARMACEUTICALS LIMITED's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
BALAXI PHARMACEUTICALS LIMITED Income Statement — Revenue, Profit & Earnings by Year
BALAXI PHARMACEUTICALS LIMITED's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | Rs2.89 Billion | Rs2.41 Billion | Rs3.36 Billion | Rs2.79 Billion | Rs2.31 Billion |
| Cost of Revenue | Rs1.71 Billion | Rs1.29 Billion | Rs2.02 Billion | Rs1.96 Billion | Rs1.72 Billion |
| Gross Profit | Rs1.27 Billion | Rs1.13 Billion | Rs1.34 Billion | Rs837.91 Million | Rs591.85 Million |
| Research & Development | — | Rs0.01 | Rs0.17 | Rs0.19 | Rs0.19 |
| SG&A | Rs445.05 Million | Rs277.95 Million | Rs312.61 Million | Rs131.41 Million | Rs5.79 Million |
| Total Operating Expenses | Rs904.62 Million | Rs656.74 Million | Rs792.32 Million | Rs334.80 Million | Rs167.68 Million |
| Operating Income | Rs363.99 Million | Rs467.31 Million | Rs586.30 Million | Rs503.11 Million | Rs424.17 Million |
| EBITDA | Rs305.64 Million | Rs456.59 Million | Rs603.82 Million | Rs560.20 Million | Rs449.86 Million |
| EBIT | Rs286.70 Million | Rs435.60 Million | Rs586.30 Million | Rs555.08 Million | Rs446.88 Million |
| Interest Expense | Rs29.35 Million | Rs16.77 Million | Rs5.00 Million | Rs1.42 Million | Rs184.00K |
| Income Before Tax | Rs286.70 Million | Rs20.15 Million | Rs569.22 Million | Rs545.22 Million | Rs443.29 Million |
| Income Tax Expense | Rs35.99 Million | Rs44.02 Million | Rs109.60 Million | Rs68.64 Million | Rs61.92 Million |
| Net Income | Rs250.70 Million | Rs-23.87 Million | Rs459.62 Million | Rs476.58 Million | Rs381.37 Million |
BALAXI PHARMACEUTICALS LIMITED Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes BALAXI PHARMACEUTICALS LIMITED's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | Rs3.10 Billion | Rs2.58 Billion | Rs2.40 Billion | Rs1.76 Billion | Rs996.80 Million |
| Total Current Assets | Rs2.43 Billion | Rs2.10 Billion | Rs1.94 Billion | Rs1.41 Billion | Rs937.71 Million |
| Cash & Equivalents | — | — | — | Rs71.93 Million | — |
| Short-term Investments | Rs13.04 Million | Rs1.00K | Rs2.44 Billion | Rs1.84 Million | — |
| Net Receivables | Rs1.11 Billion | Rs557.05 Million | Rs522.82 Million | Rs275.59 Million | Rs767.59 Million |
| Inventory | Rs784.81 Million | Rs821.68 Million | Rs1.05 Billion | Rs987.04 Million | Rs136.18 Million |
| Property, Plant & Equipment | Rs363.11 Million | Rs170.87 Million | Rs190.16 Million | Rs60.27 Million | Rs11.67 Million |
| Goodwill | Rs267.45 Million | Rs261.00 Million | Rs252.24 Million | Rs233.02 Million | Rs12.79 Million |
| Total Liabilities | Rs786.06 Million | Rs569.79 Million | Rs567.89 Million | Rs633.07 Million | Rs347.00 Million |
| Total Current Liabilities | Rs545.32 Million | Rs541.97 Million | Rs531.33 Million | Rs632.68 Million | Rs346.93 Million |
| Long-term Debt | Rs212.45 Million | Rs0.00 | Rs8.70 Million | Rs0.00 | Rs0.00 |
| Net Debt | Rs140.26 Million | Rs-428.87 Million | Rs-149.10 Million | Rs-35.55 Million | Rs19.90 Million |
| Total Stockholder Equity | Rs2.32 Billion | Rs2.01 Billion | Rs1.83 Billion | Rs1.13 Billion | Rs649.80 Million |
| Retained Earnings | Rs1.63 Billion | Rs1.36 Billion | Rs1.43 Billion | Rs918.65 Million | Rs436.81 Million |
BALAXI PHARMACEUTICALS LIMITED Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how BALAXI PHARMACEUTICALS LIMITED generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | Rs-377.82 Million | Rs48.66 Million | Rs60.75 Million | Rs341.44 Million | Rs31.00K |
| Capital Expenditures | Rs211.19 Million | Rs15.69 Million | Rs149.80 Million | Rs273.44 Million | Rs25.56 Million |
| Free Cash Flow | Rs-589.01 Million | Rs32.97 Million | Rs-89.05 Million | Rs68.00 Million | Rs-25.53 Million |
| Investing Cash Flow | Rs-217.64 Million | Rs-10.46 Million | Rs-105.65 Million | Rs-284.48 Million | Rs-59.73 Million |
| Financing Cash Flow | Rs366.55 Million | Rs302.54 Million | Rs255.13 Million | Rs-1.63 Million | Rs36.46 Million |
| Dividends Paid | Rs0.00 | — | Rs4.98 Million | Rs4.98 Million | Rs4.98 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | Rs18.95 Million | Rs20.98 Million | Rs17.52 Million | Rs5.12 Million | Rs2.98 Million |
| Change in Cash | Rs-228.91 Million | Rs340.74 Million | Rs210.22 Million | Rs55.33 Million | Rs-23.23 Million |
BALAXI PHARMACEUTICALS LIMITED Earnings History — EPS Actual vs. Analyst Estimates
Track BALAXI PHARMACEUTICALS LIMITED's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jun 30, 2023 | -40.49 | — | — |
| Dec 31, 2022 | 8.03 | — | — |
| Sep 30, 2022 | 15.49 | — | — |
| Jun 30, 2022 | 14.15 | — | — |
| Mar 31, 2022 | 12.71 | — | — |
| Feb 10, 2022 | 12.18 | — | — |
| Oct 28, 2021 | 12.05 | — | — |
| Jul 19, 2021 | 10.71 | — | — |